Rhee Chanu, Dantes Raymund, Epstein Lauren, Murphy David J, Seymour Christopher W, Iwashyna Theodore J, Kadri Sameer S, Angus Derek C, Danner Robert L, Fiore Anthony E, Jernigan John A, Martin Greg S, Septimus Edward, Warren David K, Karcz Anita, Chan Christina, Menchaca John T, Wang Rui, Gruber Susan, Klompas Michael
Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Health Care Institute, Boston, Massachusetts.
Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
JAMA. 2017 Oct 3;318(13):1241-1249. doi: 10.1001/jama.2017.13836.
IMPORTANCE: Estimates from claims-based analyses suggest that the incidence of sepsis is increasing and mortality rates from sepsis are decreasing. However, estimates from claims data may lack clinical fidelity and can be affected by changing diagnosis and coding practices over time. OBJECTIVE: To estimate the US national incidence of sepsis and trends using detailed clinical data from the electronic health record (EHR) systems of diverse hospitals. DESIGN, SETTING, AND POPULATION: Retrospective cohort study of adult patients admitted to 409 academic, community, and federal hospitals from 2009-2014. EXPOSURES: Sepsis was identified using clinical indicators of presumed infection and concurrent acute organ dysfunction, adapting Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) criteria for objective and consistent EHR-based surveillance. MAIN OUTCOMES AND MEASURES: Sepsis incidence, outcomes, and trends from 2009-2014 were calculated using regression models and compared with claims-based estimates using International Classification of Diseases, Ninth Revision, Clinical Modification codes for severe sepsis or septic shock. Case-finding criteria were validated against Sepsis-3 criteria using medical record reviews. RESULTS: A total of 173 690 sepsis cases (mean age, 66.5 [SD, 15.5] y; 77 660 [42.4%] women) were identified using clinical criteria among 2 901 019 adults admitted to study hospitals in 2014 (6.0% incidence). Of these, 26 061 (15.0%) died in the hospital and 10 731 (6.2%) were discharged to hospice. From 2009-2014, sepsis incidence using clinical criteria was stable (+0.6% relative change/y [95% CI, -2.3% to 3.5%], P = .67) whereas incidence per claims increased (+10.3%/y [95% CI, 7.2% to 13.3%], P < .001). In-hospital mortality using clinical criteria declined (-3.3%/y [95% CI, -5.6% to -1.0%], P = .004), but there was no significant change in the combined outcome of death or discharge to hospice (-1.3%/y [95% CI, -3.2% to 0.6%], P = .19). In contrast, mortality using claims declined significantly (-7.0%/y [95% CI, -8.8% to -5.2%], P < .001), as did death or discharge to hospice (-4.5%/y [95% CI, -6.1% to -2.8%], P < .001). Clinical criteria were more sensitive in identifying sepsis than claims (69.7% [95% CI, 52.9% to 92.0%] vs 32.3% [95% CI, 24.4% to 43.0%], P < .001), with comparable positive predictive value (70.4% [95% CI, 64.0% to 76.8%] vs 75.2% [95% CI, 69.8% to 80.6%], P = .23). CONCLUSIONS AND RELEVANCE: In clinical data from 409 hospitals, sepsis was present in 6% of adult hospitalizations, and in contrast to claims-based analyses, neither the incidence of sepsis nor the combined outcome of death or discharge to hospice changed significantly between 2009-2014. The findings also suggest that EHR-based clinical data provide more objective estimates than claims-based data for sepsis surveillance.
重要性:基于索赔分析的估计表明,脓毒症的发病率在上升,而脓毒症的死亡率在下降。然而,基于索赔数据的估计可能缺乏临床准确性,并且可能会受到随时间变化的诊断和编码实践的影响。 目的:使用来自不同医院电子健康记录(EHR)系统的详细临床数据,估计美国全国脓毒症的发病率和趋势。 设计、设置和人群:对2009年至2014年入住409家学术、社区和联邦医院的成年患者进行回顾性队列研究。 暴露因素:使用假定感染的临床指标和并发的急性器官功能障碍来识别脓毒症,采用《脓毒症和脓毒性休克第三次国际共识定义》(Sepsis-3)标准进行基于EHR的客观且一致的监测。 主要结局和指标:使用回归模型计算2009年至2014年的脓毒症发病率、结局和趋势,并与使用《国际疾病分类,第九次修订本,临床修订版》严重脓毒症或脓毒性休克编码的基于索赔的估计值进行比较。通过病历审查,根据Sepsis-3标准对病例发现标准进行验证。 结果:在2014年入住研究医院的2901019名成年人中,使用临床标准共识别出173690例脓毒症病例(平均年龄66.5岁[标准差15.5岁];77660例[42.4%]为女性)(发病率6.0%)。其中,26061例(15.0%)在医院死亡,10731例(6.2%)出院后进入临终关怀。从2009年至2014年,使用临床标准的脓毒症发病率稳定(相对变化+0.6%/年[95%置信区间,-2.3%至3.5%],P = 0.67),而基于索赔的发病率上升(+10.3%/年[95%置信区间,7.2%至13.3%],P < 0.001)。使用临床标准的住院死亡率下降(-3.3%/年[95%置信区间,-5.6%至-1.0%],P = 0.004),但死亡或出院后进入临终关怀的综合结局无显著变化(-1.3%/年[95%置信区间,-3.2%至0.6%],P = 0.19)。相比之下,基于索赔的死亡率显著下降(-7.0%/年[95%置信区间,-8.8%至-5.2%],P < 0.001),死亡或出院后进入临终关怀的情况也是如此(-4.5%/年[95%置信区间,-6.1%至-2.8%],P < 0.001)。临床标准在识别脓毒症方面比索赔更敏感(69.7%[95%置信区间,52.9%至92.0%]对32.3%[95%置信区间,24.4%至43.0%],P < 0.001),阳性预测值相当(70.4%[95%置信区间,64.0%至76.8%]对75.2%[95%置信区间,69.8%至80.6%],P = 0.23)。 结论与意义:在409家医院的临床数据中,6%的成年住院患者存在脓毒症,与基于索赔的分析不同,2009年至2014年期间脓毒症的发病率以及死亡或出院后进入临终关怀的综合结局均无显著变化。研究结果还表明,基于EHR的临床数据在脓毒症监测方面比基于索赔的数据提供了更客观的估计。
Infect Control Hosp Epidemiol. 2016-2
Ann Am Thorac Soc. 2015-2
Pediatr Crit Care Med. 2020-2
Crit Care Med. 2016-7
Crit Care Med. 2016-3